Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma Diagnosis

Recruiting now · Not applicable

Conditions studied: Suspected Asthma

In brief

This is a multi-center study to explore the positive predictive value of bronchodilation test with portable oscillometry compared to either BDT or BPT with spirometry in asthma diagnosis and to compare it with bronchodilation with spirometry (the current gold standard). In the study, the target patients' profile is the suspected asthma patient with asthmatic symptoms (wheezing, shortness of breath, chest tightness, and/or cough) and aim to enroll 500 participants from 25 sites across different regions in China.

Key facts

Study ID: NCT07516184
Run by: AstraZeneca
People needed: 500
Starts: 2026-06-10
Expected to finish: 2027-06-11
Last updated by the study team: 2026-06-23

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Participants must meet all the following criteria and sign an informed consent form (ICF) to be eligible for the study.
Patient must be aged 18-75 years old at the time of enrollment.
Presented with asthmatic symptoms such as wheezing, shortness of breath, chest tightness and cough ≥2 months prior to enrollment (Day 0), with/without an established asthma diagnosis.

You may not qualify if…

Patients are excluded from the study if any of the following criteria apply:
Medical Conditions
Respiratory infections within 3 months prior to enrollment (Day 0), including but not limited to: acute bacterial/viral pneumonia, acute bronchitis, Influenza, COVID-19 or acute exacerbation of chronic bronchitis.
Current smoker; or cessation from smoking less than 6 months; or cessation smoking for more than 6 months but smoked more than 10 packs/year.
History of other chronic respiratory diseases other than asthma, including but not limited to tuberculosis, significant bronchiectasis, established interstitial lung disease, and lung cancer.
History of serious comorbidities, including, but not limited to, cardiovascular, gastrointestinal, hepatic, renal, neurological, musculoskeletal, infectious, endocrine, metabolic, haematological, psychiatric, or major physical impairment that is not stable in the opinion of the investigator and could:
Affect the safety of the patient throughout the study,
Confound the study results or impact the scientific validity of the data outcome,
Impede the patient's ability to complete the entire duration of study.
Positive urine pregnancy test, or breastfeeding women, or any women who are planning to become pregnant (current and within 3 months).
Prior/Concomitant Therapy
ICS-based medication (including ICS, ICS/LABA, ICS/LABA/LAMA) use within 3 months prior to enrollment (Day 0).
ICS=inhaled corticosteroids; LABA=long-acting β2 agonists; LAMA=long-acting muscarinic antagonists.
Other Exclusions
Judgment by the investigator that the participant should not participate in the study if the participant is unlikely to comply with study procedures, restrictions, and requirements.
Current participation in another interventional clinical trial.

Where it is running

Research Site — Shanghai, China (enrolling)
Research Site — Beijing, China (enrolling)
Research Site — Changsha, China
Research Site — Changsha, China
Research Site — Chengdu, China
Research Site — Chongqing, China
Research Site — Guangzhou, China
Research Site — Guangzhou, China
Research Site — Guangzhou, China
Research Site — Kunming, China
Research Site — Quanzhou, China
Research Site — Shanghai, China
Research Site — Shanghai, China
Research Site — Shanghai, China
Research Site — Suzhou, China
Research Site — Taiyuan, China
Research Site — Tianjin, China
Research Site — Ürümqi, China
Research Site — Wuhan, China
Research Site — Xi'an, China
Research Site — Yangzhou, China
Research Site — Zhengzhou, China
Research Site — Zhuhai, China
Research Site — Cangzhou, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.